If, however, STI571 is shown to reduce progression to blast crisis and to obliterate all molecular evidence of residual leukemia, the role of transplantation in CML will have to be reevaluated.

• 不过，一旦发现STI571可减少疾病向急性发作期的发展或能清除所有残余的白血病标志分子，那就应该对干细胞移植疗法在CML治疗中的地位进行重新评价了。